Our research suggests that SLC7A11, NQO‐1, and FTO may be potential useful genes for identifying smokers at risk of COPD, and provide references and new ideas for the prevention and treatment of COPD as well as the research and development of future targeted drugs. This evidence concerns the gene SLC7A11 and chronic obstructive pulmonary disease.